Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Potential Biomarkers in Prostate Cancer Microarray Gene Expression Leveraging Explainable Machine Learning Classifiers.

Cancers·2025
Same author

Integrating Multi-Omics and Medical Imaging in Artificial Intelligence-Based Cancer Research: An Umbrella Review of Fusion Strategies and Applications.

Cancers·2025
Same author

Leveraging Machine Learning for Severity Level-Wise Biomarker Identification in Prostate Cancer Microarray Gene Expression Data.

Biomedicines·2025
Same author

Investigating the impact of social media images on users' sentiments towards sociopolitical events based on deep artificial intelligence.

PloS one·2025
Same author

LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment.

PloS one·2024
Same author

Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning.

Cancers·2023
Same journal

Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. <i>Diagnostics</i> 2026, <i>16</i>, 1224.

Diagnostics (Basel, Switzerland)·2026
Same journal

Association Between Systemic Inflammatory Response Biomarkers and Disease Activity in Systemic Lupus Erythematosus: A Multi-Center Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same journal

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same journal

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation.

Diagnostics (Basel, Switzerland)·2026
Same journal

Data-Efficient and Explainable Multimodal Survival Prediction in NSCLC Using Deep Image Embeddings, Clinical Variables, and Gradient-Boosted Trees.

Diagnostics (Basel, Switzerland)·2026
Same journal

Anomalous Left Coronary Artery from the Pulmonary Artery: Cinematic Volume Rendering Technique for Enhanced Anatomic Visualization.

Diagnostics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Lightweight Deep Learning Models with Explainable AI for Early Alzheimer's Detection from Standard MRI Scans.

Falah Sheikh1, Ahmed Al Marouf1, Jon George Rokne1

  • 1Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.

Diagnostics (Basel, Switzerland)
|November 13, 2025
PubMed
Summary
This summary is machine-generated.

This study developed lightweight deep learning models for early Alzheimer's Disease (AD) detection using MRI scans. The EfficientNetV2B0 model achieved 88% accuracy, offering an accessible tool for clinical diagnosis.

Keywords:
Alzheimer’s diseaseEfficientNetV2B0, MobileNetV2deep learning

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Dementia, including Alzheimer's Disease (AD), affects millions globally, with diagnosis challenging in resource-limited settings.
  • Current diagnostic methods for AD often rely on costly neuroimaging and specialist expertise, hindering early detection.
  • Early diagnosis of AD is critical for managing symptoms and slowing disease progression.

Purpose of the Study:

  • To develop and evaluate computationally efficient deep learning models for early Alzheimer's Disease detection.
  • To address the challenge of accessible and timely AD diagnosis in clinical practice.
  • To enhance the interpretability of AI models in neuroimaging for clinical trust.

Main Methods:

  • Utilized lightweight deep learning models, MobileNetV2 and EfficientNetV2B0.
  • Trained models on 2D structural magnetic resonance imaging (MRI) slices for early AD detection.
  • Applied explainability methods (Grad-CAM++, Guided Grad-CAM++) for model interpretability.

Main Results:

  • The EfficientNetV2B0 model achieved 88.0% mean accuracy in distinguishing between Cognitively Normal (CN), Early Mild Cognitive Impairment (EMCI), and Late Mild Cognitive Impairment (LMCI).
  • The model demonstrated strong performance in a multi-class classification task.
  • Explainability methods successfully visualized the anatomical regions influencing model predictions.

Conclusions:

  • Developed an accessible and interpretable neuroimaging tool for early AD diagnosis.
  • The proposed deep learning models can extend expert-level diagnostic capabilities to routine clinical settings.
  • This approach facilitates earlier intervention and management of Alzheimer's Disease.